Fundraising FoxConcentric Analgesics
Los Altos, US · Founded 2014 · Delaware corporation · 5 known investors
Find your way into Concentric Analgesics
Sign up to find every way you can get introduced to Concentric Analgesics
- Your email: who you already know at Concentric Analgesics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Concentric Analgesics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Board
CH
Craig HusfeldBoard director
Investors · 5
Also in the syndicate · 2
Kern Whelan CapitalOracle Investment Managementlead
Reported raises · per SEC filings
Form D private placements$130.8M disclosed across 5 rounds · 2016–2021
▶$20MraisedDec 2021 · 116 investors · BiotechnologyRule 506(b)
▶$20MraisedDec 2021 · 116 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John F. DonovanExecutive Officer, Director
- Frank J. BellizziExecutive Officer, Director
- Thomas KingExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $20M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$77.1MraisedMay 2019 · 144 investors · BiotechnologyRule 506(b)
▶$77.1MraisedMay 2019 · 144 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank J. BellizziExecutive Officer, Director
- Larry FeinbergDirector
- Thomas KingExecutive Officer, Director
- John F. DonovanExecutive Officer, Director
- Offering amount
- $77.1M
- Amount sold
- $77.1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$20MraisedNov 2018 · 109 investors · BiotechnologyRule 506(b)
▶$20MraisedNov 2018 · 109 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank BellizziExecutive Officer, Director
- Thomas KingExecutive Officer, Director
- Craig HusfeldExecutive Officer
- John DonovanExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$5.4MraisedDec 2017 · 79 investors · BiotechnologyRule 506(b)
▶$5.4MraisedDec 2017 · 79 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank BellizziExecutive Officer, Director
- Craig HusfeldExecutive Officer
- John DonovanExecutive Officer, Director
- Thomas KingDirector
- Offering amount
- $7M
- Amount sold
- $5.4M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$8.4MraisedDec 2016 · 82 investors · BiotechnologyRule 506(b)
▶$8.4MraisedDec 2016 · 82 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig HusfeldDirector
- John F. DonovanExecutive Officer, Director
- Frank J. BellizziExecutive Officer
- Offering amount
- $9.6M
- Amount sold
- $8.4M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Concentric Analgesics's investors?
- Concentric Analgesics's investors include Kern Capital, LLC, Cowen Healthcare Investments, Venrock Healthcare Capital Partners.
- How much funding has Concentric Analgesics raised?
- Concentric Analgesics has disclosed $130.8M raised across 5 rounds.
- Where is Concentric Analgesics headquartered?
- Concentric Analgesics is headquartered in Los Altos, US.